Biomarkers' may help to improve detection and treatment of gastrointestinal diseases such as gastric cancer, colorectal cancer, and inflammatory bowel disease.

In May Janssen acquired BeneVir BioPharm – a private biotech developing a proprietary oncolytic virus platform to be used in combination with checkpoint inhibitors – for just over $1 billion.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Aggressive breast cancer can become unresponsive to monoclonal antibody treatment, but targeting tumor-resident bacteria may extend its effectiveness.